Mechanisms of Helicobacter pylori antibiotic resistance and molecular testing

Frontiers in Molecular Biosciences

Volumn 1, Issue OCT, 2014, Pages

  Nishizawa, Toshihiro ^a   Suzuki, Hidekazu ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

16S rRNA; 23S rRNA; GyrA; Helicobacter pylori; PBP1

Indexed keywords

EID: 84983239279     PISSN: None     EISSN: 2296889X     Source Type: Journal    
DOI: 10.3389/fmolb.2014.00019     Document Type: Review

References (55)

1. Asaka, M., Kato, M., Takahashi, S., Fukuda, Y., Sugiyama, T., Ota, H., et al. (2010). Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition. Helicobacter 15, 1-20. doi: 10.1111/j.1523-5378.2009.00738.x
2. Banatvala, N., Davies, G. R., Abdi, Y., Clements, L., Rampton, D. S., Hardie, J. M., et al. (1994). High prevalence of Helicobacter pylori metronidazole resistance in migrants to east London: relation with previous nitroimidazole exposure and gastroduodenal disease. Gut 35, 1562-1566. doi: 10.1136/gut.35.11.1562
3. Bina, J. E., Alm, R. A., Uria-Nickelsen, M., Thomas, S. R., Trust, T. J., and Hancock, R. E. (2000). Helicobacter pylori uptake and efflux: basis for intrinsic susceptibility to antibiotics in vitro. Antimicrob. Agents Chemother. 44, 248-254. doi: 10.1128/AAC.44.2.248-254.2000
4. Cambau, E., Allerheiligen, V., Coulon, C., Corbel, C., Lascols, C., Deforges, L., et al. (2009). Evaluation of a new test, genotype HelicoDR, for molecular detection of antibiotic resistance in Helicobacter pylori. J. Clin. Microbiol. 47, 3600-3607. doi: 10.1128/JCM.00744-09
5. Can, F., Yilmaz, Z., Demirbilek, M., Bilezikci, B., Kunefeci, G., Atac, F. B., et al. (2005). Diagnosis of Helicobacter pylori infection and determination of clarithromycin resistance by fluorescence in situ hybridization from formalin-fixed, paraffin-embedded gastric biopsy specimens. Can. J. Microbiol. 51, 569-573. doi: 10.1139/w05-035
6. Cerqueira, L., Fernandes, R. M., Ferreira, R. M., Oleastro, M., Carneiro, F., Brandao, C., et al. (2013). Validation of a fluorescence in situ hybridization method using peptide nucleic acid probes for detection of Helicobacter pylori clarithromycin resistance in gastric biopsy specimens. J. Clin. Microbiol. 51, 1887-1893. doi: 10.1128/JCM.00302-13
7. Fontana, C., Favaro, M., Pietroiusti, A., Pistoia, E. S., Galante, A., and Favalli, C. (2003). Detection of clarithromycin-resistant Helicobacter pylori in stool samples. J. Clin. Microbiol. 41, 3636-3640. doi: 10.1128/JCM.41.8.3636-3640.2003
8. Francesco, V. D., Zullo, A., Hassan, C., Giorgio, F., Rosania, R., and Ierardi, E. (2011). Mechanisms of Helicobacter pylori antibiotic resistance: an updated appraisal. World J. Gastrointest. Pathophysiol. 2, 35-41. doi: 10.4291/wjgp.v2.i3.35
9. Fukase, K., Kato, M., Kikuchi, S., Inoue, K., Uemura, N., Okamoto, S., et al. (2008). Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet 372, 392-397. doi: 10.1016/S0140-6736(08)61159-9
10. Furuta, T., Soya, Y., Sugimoto, M., Nishino, M., Yamade, M., Uotani, T., et al. (2013). Rapid Automated Genotyping of CYP2C19 and Helicobacter pylori 23S rRNA Gene in Gastric Juice. J. Gastorenterol. Hepatol. Res. 2, 508-512. doi: 10.6051/j.issn.2224-3992.2013.02.221
11. Furuta, T., Soya, Y., Sugimoto, M., Shirai, N., Nakamura, A., Kodaira, C., et al. (2007). Modified allele-specific primer-polymerase chain reaction method for analysis of susceptibility of Helicobacter pylori strains to clarithromycin. J. Gastroenterol. Hepatol. 22, 1810-1815. doi: 10.1111/j.1440-1746.2007.04919.x
12. Gerrits, M. M., de Zoete, M. R., Arents, N. L., Kuipers, E. J., and Kusters, J. G. (2002). 16S rRNA mutation-mediated tetracycline resistance in Helicobacter pylori. Antimicrob. Agents Chemother. 46, 2996-3000. doi: 10.1128/AAC.46.9.2996-3000.2002
13. Gisbert, J. P., and Calvet, X. (2012). Review article: rifabutin in the treatment of refractory Helicobacter pylori infection. Aliment. Pharmacol. Ther. 35, 209-221. doi: 10.1111/j.1365-2036.2011.04937.x
14. Glocker, E., Berning, M., Gerrits, M. M., Kusters, J. G., and Kist, M. (2005). Real-time PCR screening for 16S rRNA mutations associated with resistance to tetracycline in Helicobacter pylori. Antimicrob. Agents Chemother. 49, 3166-3170. doi: 10.1128/AAC.49.8.3166-3170.2005
15. Glocker, E., and Kist, M. (2004). Rapid detection of point mutations in the gyrA gene of Helicobacter pylori conferring resistance to ciprofloxacin by a fluorescence resonance energy transfer-based real-time PCR approach. J. Clin. Microbiol. 42, 2241-2246. doi: 10.1128/JCM.42.5.2241-2246.2004
16. Heep, M., Lehn, N., Brandstatter, B., Rieger, U., Senzenberger, S., and Wehrl, W. (2002). Detection of rifabutin resistance and association of rpoB mutations with resistance to four rifamycin derivatives in Helicobacter pylori. Eur. J. Clin. Microbiol. Infect. Dis. 21, 143-145. doi: 10.1007/s10096-001-0672-2
17. Hirata, K., Suzuki, H., Nishizawa, T., Tsugawa, H., Muraoka, H., Saito, Y., et al. (2010). Contribution of efflux pumps to clarithromycin resistance in Helicobacter pylori. J. Gastroenterol. Hepatol. 25 (Suppl. 1), S75-S79. doi: 10.1111/j.1440-1746.2009.06220.x
18. Kaneko, F., Suzuki, H., Hasegawa, N., Kurabayshi, K., Saito, H., Otani, S., et al. (2004). High prevalence rate of Helicobacter pylori resistance to clarithromycin during long-term multiple antibiotic therapy for chronic respiratory disease caused by non-tuberculous mycobacteria. Aliment. Pharmacol. Ther. 20 (Suppl. 1), 62-67. doi: 10.1111/j.1365-2036.2004.01993.x
19. Klesiewicz, K., Nowak, P., Karczewska, E., Skiba, I., Wojtas-Bonior, I., Sito, E., et al. (2014). PCR-RFLP detection of point mutations A2143G and A2142G in 23S rRNA gene conferring resistance to clarithromycin in Helicobacter pylori strains. Acta Biochim. Pol. 61, 311-315
20. Kutschke, A., and de Jonge, B. L. (2005). Compound efflux in Helicobacter pylori. Antimicrob. Agents Chemother. 49, 3009-3010. doi: 10.1128/AAC.49.7.3009-3010.2005
21. Lee, J. W., Kim, N., Nam, R. H., Park, J. H., Choi, Y. J., Kim, J. M., et al. (2004). GenoType HelicoDR test in the determination of antimicrobial resistance of Helicobacter pylori in Korea. Scand. J. Gastroenterol. 49, 1058-1067. doi: 10.3109/00365521.2014.894117
22. Lehours, P., Siffre, E., and Megraud, F. (2011). DPO multiplex PCR as an alternative to culture and susceptibility testing to detect Helicobacter pylori and its resistance to clarithromycin. BMC Gastroenterol. 11:112. doi: 10.1186/1471-230X-11-112
23. Ma, D., Cook, D. N., Alberti, M., Pon, N. G., Nikaido, H., and Hearst, J. E. (1995). Genes acrA and acrB encode a stress-induced efflux system of Escherichia coli. Mol. Microbiol. 16, 45-55. doi: 10.1111/j.1365-2958.1995.tb02390.x
24. Malfertheiner, P., Megraud, F., O'Morain, C. A., Atherton, J., Axon, A. T., Bazzoli, F., et al. (2012). Management of Helicobacter pylori infection-the Maastricht IV/ Florence Consensus Report. Gut 61, 646-664. doi: 10.1136/gutjnl-2012-302084
25. Masaoka, T., Suzuki, H., Kurabayashi, K., Kamiya, A., and Ishii, H. (2004). Second-line treatment of Helicobacter pylori infection after dilution agar methods and PCR-RFLP analysis. Aliment. Pharmacol. Ther. 20 (Suppl. 1), 68-73. doi: 10.1111/j.1365-2036.2004.01994.x
26. Masaoka, T., Suzuki, H., Kurabayashi, K., Nomoto, Y., Nishizawa, T., Mori, M., et al. (2006). Could frameshift mutations in the frxA and rdxA genes of Helicobacter pylori be a marker for metronidazole resistance? Aliment. Pharmacol. Ther. 24 (Suppl. 4), 81-87. doi: 10.1111/j.1746-6342.2006.00029.x
27. Matsuzaki, J., Suzuki, H., Nishizawa, T., Hirata, K., Tsugawa, H., Saito, Y., et al. (2012). Efficacy of sitafloxacin-based rescue therapy for Helicobacter pylori after failures of first-and second-line therapies. Antimicrob. Agents Chemother. 56, 1643-1645. doi: 10.1128/AAC.05941-11
28. Matsuzaki, J., Suzuki, H., Tsugawa, H., Nishizawa, T., and Hibi, T. (2010). Homology model of the DNA gyrase enzyme of Helicobacter pylori, a target of quinolone-based eradication therapy. J. Gastroenterol. Hepatol. 25 (Suppl. 1), S7-S10. doi: 10.1111/j.1440-1746.2010.06245.x
29. Moore, R. A., Beckthold, B., Wong, S., Kureishi, A., and Bryan, L. E. (1995). Nucleotide sequence of the gyrA gene and characterization of ciprofloxacin-resistant mutants of Helicobacter pylori. Antimicrob. Agents Chemother. 39, 107-111. doi: 10.1128/AAC.39.1.107
30. Nahar, S., Mukhopadhyay, A. K., Khan, R., Ahmad, M. M., Datta, S., Chattopadhyay, S., et al. (2004). Antimicrobial susceptibility of Helicobacter pylori strains isolated in Bangladesh. J. Clin. Microbiol. 42, 4856-4858. doi: 10.1128/JCM.42.10.4856-4858.2004
31. Nishizawa, T., Maekawa, T., Watanabe, N., Harada, N., Hosoda, Y., Yoshinaga, M., et al. (2014). Clarithromycin Versus Metronidazole as First-line Helicobacter pylori Eradication: a multicenter, prospective, randomized controlled study in Japan. J. Clin. Gastroenterol. doi: 10.1097/MCG.0000000000000165. [Epub ahead of print]
32. Nishizawa, T., Suzuki, H., and Hibi, T. (2009). Quinolone-Based Third-Line Therapy for Helicobacter pylori Eradication. J. Clin. Biochem. Nutr. 44, 119-124. doi: 10.3164/jcbn.08-220R
33. Nishizawa, T., Suzuki, H., Kurabayashi, K., Masaoka, T., Muraoka, H., Mori, M., et al. (2006). Gatifloxacin resistance and mutations in gyra after unsuccessful Helicobacter pylori eradication in Japan. Antimicrob. Agents Chemother. 50, 1538-1540. doi: 10.1128/AAC.50.4.1538-1540.2006
34. Nishizawa, T., Suzuki, H., Maekawa, T., Harada, N., Toyokawa, T., Kuwai, T., et al. (2012). Dual therapy for third-line Helicobacter pylori eradication and urea breath test prediction. World J. Gastroenterol. 18, 2735-2738. doi: 10.3748/wjg.v18.i21.2735
35. Nishizawa, T., Suzuki, H., Matsuzaki, J., Muraoka, H., Tsugawa, H., Hirata, K., et al. (2011b). Helicobacter pylori resistance to rifabutin in the last 7 years. Antimicrob. Agents Chemother. 55, 5374-5375. doi: 10.1128/AAC.05437-11
36. Nishizawa, T., Suzuki, H., Nakagawa, I., Iwasaki, E., Masaoka, T., and Hibi, T. (2008). Gatifloxacin-based triple therapy as a third-line regimen for Helicobacter pylori eradication. J. Gastroenterol. Hepatol. 23 (Suppl. 2), S167-S170. doi: 10.1111/j.1440-1746.2008.05407.x
37. Nishizawa, T., Suzuki, H., Tsugawa, H., Muraoka, H., Matsuzaki, J., Hirata, K., et al. (2011a). Enhancement of amoxicillin resistance after unsuccessful Helicobacter pylori eradication. Antimicrob. Agents Chemother. 55, 3012-3014. doi: 10.1128/AAC.00188-11
38. Nishizawa, T., Suzuki, H., Umezawa, A., Muraoka, H., Iwasaki, E., Masaoka, T., et al. (2007). Rapid detection of point mutations conferring resistance to fluoroquinolone in gyrA of Helicobacter pylori by allele-specific PCR. J. Clin. Microbiol. 45, 303-305. doi: 10.1128/JCM.01997-06
39. Oleastro, M., Menard, A., Santos, A., Lamouliatte, H., Monteiro, L., Barthelemy, P., et al. (2003). Real-time PCR assay for rapid and accurate detection of point mutations conferring resistance to clarithromycin in Helicobacter pylori. J. Clin. Microbiol. 41, 397-402. doi: 10.1128/JCM.41.1.397-402.2003
40. Ribeiro, M. L., Gerrits, M. M., Benvengo, Y. H., Berning, M., Godoy, A. P., Kuipers, E. J., et al. (2004). Detection of high-level tetracycline resistance in clinical isolates of Helicobacter pylori using PCR-RFLP. FEMS Immunol. Med. Microbiol. 40, 57-61. doi: 10.1016/S0928-8244(03)00277-3
41. Rimbara, E., Noguchi, N., Kawai, T., and Sasatsu, M. (2012). Fluoroquinolone resistance in Helicobacter pylori: role of mutations at position 87 and 91 of GyrA on the level of resistance and identification of a resistance conferring mutation in GyrB. Helicobacter 17, 36-42. doi: 10.1111/j.1523-5378.2011.00912.x
42. Scaletsky, I. C., Aranda, K. R., Garcia, G. T., Goncalves, M. E., Cardoso, S. R., Iriya, K., et al. (2011). Application of real-time PCR stool assay for Helicobacter pylori detection and clarithromycin susceptibility testing in Brazilian children. Helicobacter 16, 311-315. doi: 10.1111/j.1523-5378.2011.00845.x
43. Schabereiter-Gurtner, C., Hirschl, A. M., Dragosics, B., Hufnagl, P., Puz, S., Kovach, Z., et al. (2004). Novel real-time PCR assay for detection of Helicobacter pylori infection and simultaneous clarithromycin susceptibility testing of stool and biopsy specimens. J. Clin. Microbiol. 42, 4512-4518. doi: 10.1128/JCM.42.10.4512-4518.2004
44. Stone, G. G., Shortridge, D., Versalovic, J., Beyer, J., Flamm, R. K., Graham, D. Y., et al. (1997). A PCR-oligonucleotide ligation assay to determine the prevalence of 23S rRNA gene mutations in clarithromycin-resistant Helicobacter pylori. Antimicrob. Agents Chemother. 41, 712-714
45. Suerbaum, S. (2000). Genetic variability within Helicobacter pylori. Int. J. Med. Microbiol. 290, 175-181. doi: 10.1016/S1438-4221(00)80087-9
46. Suzuki, H., Nishizawa, T., and Hibi, T. (2010). Helicobacter pylori eradication therapy. Future Microbiol. 5, 639-648. doi: 10.2217/fmb.10.25
47. Suzuki, H., Nishizawa, T., Muraoka, H., and Hibi, T. (2009a). Sitafloxacin and garenoxacin may overcome the antibiotic resistance of Helicobacter pylori with gyrA mutation. Antimicrob. Agents Chemother. 53, 1720-1721. doi: 10.1128/AAC.00049-09
48. Suzuki, S., Suzuki, H., Nishizawa, T., Kaneko, F., Ootani, S., Muraoka, H., et al. (2009b). Past rifampicin dosing determines rifabutin resistance of Helicobacter pylori. Digestion. 79, 1-4. doi: 10.1159/000191204
49. Tseng, Y. S., Wu, D. C., Chang, C. Y., Kuo, C. H., Yang, Y. C., Jan, C. M., et al. (2009). Amoxicillin resistance with beta-lactamase production in Helicobacter pylori. Eur. J. Clin. Invest. 39, 807-812. doi: 10.1111/j.1365-2362.2009.02166.x
50. Tsugawa, H., Suzuki, H., Satoh, K., Hirata, K., Matsuzaki, J., Saito, Y., et al. (2011). Two amino acids mutation of ferric uptake regulator determines Helicobacter pylori resistance to metronidazole. Antioxid. Redox Signal. 14, 15-23. doi: 10.1089/ars.2010.3146
51. Versalovic, J., Shortridge, D., Kibler, K., Griffy, M. V., Beyer, J., Flamm, R. K., et al. (1996). Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrob. Agents Chemother. 40, 477-480
52. Wang, G., Rahman, M. S., Humayun, M. Z., and Taylor, D. E. (1999). Multiplex sequence analysis demonstrates the competitive growth advantage of the A-to-G mutants of clarithromycin-resistant Helicobacter pylori. Antimicrob. Agents Chemother. 43, 683-685
53. Wu, J. Y., Wang, S. S., Lee, Y. C., Yamaoka, Y., Graham, D. Y., Jan, C. M., et al. (2014). Detection of genotypic clarithromycin-resistant Helicobacter pylori by string tests. World J. Gastroenterol. 20, 3343-3349. doi: 10.3748/wjg.v20.i12.3343
54. Xuan, S. H., Zhou, Y. G., Shao, B., Cui, Y. L., Li, J., Yin, H. B., et al. (2009). Enzymic colorimetry-based DNA chip: a rapid and accurate assay for detecting mutations for clarithromycin resistance in the 23S rRNA gene of Helicobacter pylori. J. Med. Microbiol. 58(Pt 11), 1443-1448. doi: 10.1099/jmm.0.010785-0
55. Zhang, Y., Gao, W., Cheng, H., Zhang, X., and Hu, F. (2014). Tetracycline-and Furazolidone-containing Quadruple Regimen as Rescue Treatment for Helicobacter pylori Infection: a single center retrospective study. Helicobacter 19, 382-386. doi: 10.1111/hel.12143